More importantly, transfection of anti-miR-155 into CD34+ CML cells pre-treated with BMP and TGF-β1 induced 66.4 % of cell apoptosis in 48 hours. The gene discussed is TGFB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.